Cite
HARVARD Citation
Sallette, M. et al. (n.d.). DOP36 Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter study. Journal of Crohn's and colitis. pp. i084-i085. [Online].